Inderpal Singh
General Counsel bei IMMUNIC, INC.
Aktive Positionen von Inderpal Singh
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
IMMUNIC, INC. | General Counsel | 01.06.2021 | - |
Karriereverlauf von Inderpal Singh
Ehemalige bekannte Positionen von Inderpal Singh
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Sandoz International GmbH
Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | Corporate Officer/Principal | 01.01.2018 | 01.06.2021 |
MERCK KGAA | Corporate Officer/Principal | 01.01.2015 | 01.01.2017 |
Biogen International GmbH
Biogen International GmbH Pharmaceuticals: MajorHealth Technology Biogen International GmbH produces pharmaceuticals. It develops medicines for psoriasis and multiple sclerosis. Its products include FUMADERM and BG-12. The company was founded in 1983 and is headquartered in Lucerne, Switzerland. | Corporate Officer/Principal | 01.01.2013 | 01.01.2015 |
Ausbildung von Inderpal Singh
University of Mannheim | Masters Business Admin |
Insead Business School | Masters Business Admin |
Statistik
International
Deutschland | 4 |
Vereinigte Staaten | 2 |
Frankreich | 2 |
Operativ
Corporate Officer/Principal | 3 |
Masters Business Admin | 2 |
General Counsel | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
IMMUNIC, INC. | Health Technology |
MERCK KGAA | Health Technology |
Private Unternehmen | 2 |
---|---|
Sandoz International GmbH
Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | Health Technology |
Biogen International GmbH
Biogen International GmbH Pharmaceuticals: MajorHealth Technology Biogen International GmbH produces pharmaceuticals. It develops medicines for psoriasis and multiple sclerosis. Its products include FUMADERM and BG-12. The company was founded in 1983 and is headquartered in Lucerne, Switzerland. | Health Technology |
- Börse
- Insiders
- Inderpal Singh
- Erfahrung